Ipilimumab/nivolumabCentral adrenal insufficiency due to hypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1775卷 / 1期

关键词：

D O I：

10.1007/s40278-019-69969-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：268 / 268

相关论文

共 50 条

[1] Ipilimumab/nivolumabHyponatraemia, hypophysitis and adrenal insufficiency: case report
[J]. Reactions Weekly, 2022, 1923 (1) : 270 - 270
[2] NivolumabCentral adrenal insufficiency: case report
[J]. Reactions Weekly, 2018, 1718 (1) : 172 - 172
[3] NivolumabCentral adrenal insufficiency: case report
[J]. Reactions Weekly, 2018, 1714 (1) : 294 - 294
[4] Ipilimumab/nivolumabAdrenal insufficiency and hypophysitis: case report
[J]. Reactions Weekly, 2017, 1662 (1) : 213 - 213
[5] Ipilimumab/nivolumabAdrenal insufficiency and hypophysitis: case report
[J]. Reactions Weekly, 2022, 1920 (1) : 265 - 265
[6] CemiplimabOrthostatic hypotension and secondary adrenal insufficiency due to hypophysitis: case report
[J]. Reactions Weekly, 2023, 1964 (1) : 129 - 129
[7] NivolumabCentral diabetes insipidus and hypophysitis: case report
[J]. Reactions Weekly, 2020, 1802 (1) : 219 - 219
[8] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
[J]. Reactions Weekly, 2017, 1661 (1) : 182 - 182
[9] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
[J]. Reactions Weekly, 2020, 1816 (1) : 191 - 191
[10] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
[J]. Reactions Weekly, 2021, 1874 (1) : 149 - 149

← 1 2 3 4 5 →